HKU COVID-19 vaccine trials to start in July
Share - WeChat

A COVID-19 vaccine developed by the University of Hong Kong is expected to begin human trials in July, according to He Yiwu, who leads the HKU vaccine team. However, he told China Daily on Monday that border control could slow down the vaccine manufacturing process as the city must rely on mainland manufacturers. He called for a green channel to facilitate mainland-Hong Kong collaboration in vaccine development.
- China sees robust growth in geographical indication products
- Veteran Zhang Kexia recalls boosting morale during wartime
- China launches green methanol bunkering at Dalian Port
- Discover Bodu River Cultural Center with Elliot in Wuxi
- Village Super League to return after flood repairs
- China sees vibrant innovation in green, low-carbon technologies